Yearly Archives: 2019
Interview with Dr. Dov Rubin, CEO of Lev-El Diagnostics on HeartTrends
Dr. Dov Rubin, CEO of Lev-El Diagnostics talks about how HeartTrends can be used in the early detection of myocardial ischemia, how it differs from traditional stress testing and more.
Perfect AAA EVAR Stent Has Not Been Designed or Produced: All Current AAA EVAR Devices are Obsolete
AAA EVAR Stent: Opinion from Dr. Sherif Sultan.
The Hip Hook: Releases Unresolved Pain by Simply Laying on It
After countless successes releasing the iliacus with her hands and no effective tools on the market for people to release it themselves, Christine was compelled to create the Hip Hook, the only tool that can replicate the iliacus muscle release that only a skilled practitioner could previously provide.
Three Questions Medical Product Business Owners Should Ask About Private Investments
By: John Geis, Principal of Cresset Partners
Owners of privately held medical product companies who either want to take their businesses to the next level or be rewarded for their years of hard work through a liquidity event often look to private investments to make that happen, since the money...
Dr. Robert Marema: It’s Time to Prioritize Surgeons’ Quality of Life
Dr. Marema starts off saying: "For starters, the Association of American Medical Colleges forecasts a deficit of between 33,500 and 61,800 surgeons and specialists by 2030." Read on.
Ronald Murphy Named New CEO of Theromics Inc. and Dr. Joseph Amaral Appointed to Board of Directors
Ronald Murlphy will assume responsibilities on April 18, 2019 and will succeed Thomas Ryan.
Dr. Mary Norine Walsh Joins SOLVE CRT Clinical Study as Co-Principal Investigator
Dr. Mary Norine Walsh joins SOLVE CRT Clinical Study as co-principal investigator. The news was announced today by EBR Systems.
Daniel Geffken Appointed to Windtree Therapeutics Board of Directors: Track Record Expands Many Decades
Daniel Geffken has been appointed to Windtreee Therapeutics board of directors effective April 24, 2019. The news was announced today.
Invicro and iThera Medical Strategic Partnership Will Enhance in vivo Imaging Capabilities with the MSOT inVision Optoacoustic Imaging Platform
Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the placement of the MSOT inVision Optoacoustic imaging platform in Invicro’s in vivo laboratory out of its Boston headquarters. Both companies will come together to uniquely offer Pharmaceutical, Biotech and Academia sponsors services from the optoacoustic platform that will identify and quantify disease-related biomarkers at both a molecular and anatomical level through pre-clinical full body tomographic scans.
Ablacon, Inc. Raises $21.5M Series A to Advance AI-Enabled Atrial Fibrillation Mapping System
Ablacon, Inc. today announced the closing of a $21.5 million Series A financing round led by Ajax Health.